A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.

@article{Lobatn2013ANR,
  title={A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.},
  author={Triana Lobat{\'o}n and Alicia L{\'o}pez-Garc{\'i}a and Francisco Rodr{\'i}guez-Moranta and Alexandra Ruiz and Lorena Rodr{\'i}guez and Jordi Guardiola},
  journal={Journal of Crohn's & colitis},
  year={2013},
  volume={7 12},
  pages={e641-51}
}
INTRODUCTION Fecal calprotectin (FC), as determined by the enzyme-linked immunoassay (ELISA) test, has been proposed as a promising biomarker of endoscopic activity in Crohn's disease (CD). However data on its accuracy in predicting endoscopic remission according to location and postoperative recurrence (POR) is scarce. Our objective was to evaluate the ability of FC determined by a new quantitative point-of-care test (FC-QPOCT) to predict endoscopic remission and POR in CD patients. METHODS… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Evaluation of the Quantum Blue rapid test for faecal calprotectin

  • Michael Wallage Wassell, Ella Brewer
  • Ann Clin Biochem Jan
  • 2012

Similar Papers

Loading similar papers…